Page last updated: 2024-10-22

acetaminophen and Disease Exacerbation

acetaminophen has been researched along with Disease Exacerbation in 58 studies

Acetaminophen: Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
paracetamol : A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group.

Research Excerpts

ExcerptRelevanceReference
"We conducted a meta-analysis of randomized controlled trials (RCTs) that compared wheezing and asthma exacerbations in children taking paracetamol versus ibuprofen."9.05Risk of wheezing and asthma exacerbation in children treated with paracetamol versus ibuprofen: a systematic review and meta-analysis of randomised controlled trials. ( Furuya-Kanamori, L; Nader, JD; Sherbash, M; Thalib, L, 2020)
"Several studies have shown that colchicine exhibits an improvement in the symptoms of knee osteoarthritis (OA) but its effect on disease progression is unknown."7.88Does long term colchicine prevent degradation of collagen fiber network in osteoarthritis? ( Agarwal, GG; Asthana, A; Das, SK; Goel, G; Srivastava, R, 2018)
"The objectives of this study are to determine the effects of regularly scheduled administration of paracetamol (acetaminophen) on quality of life (QoL), discomfort, pain and neuropsychiatric symptoms of persons with dementia living in long-term care facilities (LTCFs)."5.34Does paracetamol improve quality of life, discomfort, pain and neuropsychiatric symptoms in persons with advanced dementia living in long-term care facilities? A randomised double-blind placebo-controlled crossover (Q-PID) trial. ( Achterberg, WP; Caljouw, MAA; Husebo, BS; van Dam, PH, 2020)
"We conducted a meta-analysis of randomized controlled trials (RCTs) that compared wheezing and asthma exacerbations in children taking paracetamol versus ibuprofen."5.05Risk of wheezing and asthma exacerbation in children treated with paracetamol versus ibuprofen: a systematic review and meta-analysis of randomised controlled trials. ( Furuya-Kanamori, L; Nader, JD; Sherbash, M; Thalib, L, 2020)
" However, randomized trials have demonstrated success with high-dose steroids, cyclosporine, and mycophenolate in treating glomerulonephritis and other complications."5.05Henoch-Schönlein Purpura (IgA Vasculitis): Rapid Evidence Review. ( Reamy, BV; Servey, JT; Williams, PM, 2020)
"Several studies have shown that colchicine exhibits an improvement in the symptoms of knee osteoarthritis (OA) but its effect on disease progression is unknown."3.88Does long term colchicine prevent degradation of collagen fiber network in osteoarthritis? ( Agarwal, GG; Asthana, A; Das, SK; Goel, G; Srivastava, R, 2018)
" For example, epidemiological evidence suggests that coexistent hepatitis C virus (HCV) infection increased the risk of acetaminophen-induced acute liver injury, and was associated with an increased risk of progression to acute liver failure."3.79Acetaminophen-induced acute liver injury in HCV transgenic mice. ( Boorman, GA; Bradford, BU; Chatterjee, S; Jeannot, E; Kosyk, O; Macdonald, JM; Mason, RP; Melnyk, SB; Pogribny, IP; Rusyn, I; Tech, K; Tryndyak, VP; Uehara, T, 2013)
"To determine the clinical characteristics of patients with acute liver failure of indeterminate cause and their long-term outcome in comparison with patients with acute liver failure of obvious aetiology (acetaminophen and mushroom poisoning, Budd-Chiari syndrome, acute viral hepatitis) and other controls (idiosyncratic drug reactions, autoimmune hepatitis and Wilson's disease)."3.74Long-term follow-up of patients with acute liver failure of indeterminate aetiology. ( Bergquist, A; Björnsson, E; Kalaitzakis, E; Wei, G, 2008)
"To describe an in vivo model in the rat in which change in weight distribution is used as a measure of disease progression and efficacy of acetaminophen and two nonsteroidal anti-inflammatory drugs (NSAIDs) in a model of monosodium iodoacetate (MIA)-induced osteoarthritis (OA)."3.72Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. ( Bove, SE; Brooker, RM; Calcaterra, SL; Guzman, RE; Huber, CM; Juneau, PL; Kilgore, KS; Schrier, DJ, 2003)
"Hydrocodone is frequently prescribed in combination with acetaminophen for the relief of pain and has a side effects profile similar to other medications in its class."3.70Profound hearing loss associated with hydrocodone/acetaminophen abuse. ( Friedman, RA; Gherini, S; House, JW; Luxford, WM; Mills, D, 2000)
"Severe infarcts and intracerebral hemorrhages caused temperature to rise, whereas initially increased temperature had no influence on stroke severity."2.70Stroke severity determines body temperature in acute stroke. ( Boysen, G; Christensen, H, 2001)
" There is concern that current NAC dosing is not large enough to adequately treat large APAP ingestions."2.61Evaluation and treatment of acetaminophen toxicity. ( Curry, SC; Fisher, ES, 2019)
" Only pCGS is given as a highly bioavailable once daily dose (1500 mg) with a proven pharmacological effect."2.53A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes. ( Bruyère, O; Cooper, C; Kovalenko, V; Kucharz, EJ; Reginster, JY; Szántó, S, 2016)
" NSAIDs long-term use associated with serious adverse effects."2.48[Antiinflammatory therapy in ostheoarthritis including omega 3 and omega 6 fatty acids]. ( Dzielska-Olczak, M; Nowak, JZ, 2012)
"Primary osteoarthritis is mostly related to aging, whereas, secondary osteoarthritis is caused by another disease or condition."2.43Osteoarthritis. ( Mahajan, A; Tandon, V; Verma, S, 2005)
"Given that chronic obstructive pulmonary disease (COPD) is frequently co-morbid with osteoarthritis, this study investigated whether the dose and timing of paracetamol exposure may induce COPD exacerbations."1.72The association between exacerbation of chronic obstructive pulmonary disease and timing of paracetamol use: a cohort study in elderly Australians. ( Gillam, M; Kelly, TL; Pratt, NL; Ramsay, E; Roughead, EE; Ward, M, 2022)
"Human liver slice function was stressed by daily dosing of acetaminophen (APAP) or diclofenac (DCF) to investigate injury and repair."1.48Progression of Repair and Injury in Human Liver Slices. ( Fisher, RL; Ulyanov, AV; Vickers, AEM, 2018)
"Pediatric acute-liver-failure due to acetaminophen (APAP) administration at therapeutic dosage is rare, while viral infections and metabolic defects are the prevalent causes."1.46NBAS mutations cause acute liver failure: when acetaminophen is not a culprit. ( Brunati, A; Calvo, PL; Haak, TB; Olio, DD; Pinon, M; Romagnoli, R; Spada, M; Tandoi, F, 2017)
"Acetaminophen use was associated with active disease at follow-up in CD (adjusted RR, 1."1.43Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel Disease. ( Anton, K; Chen, W; Kappelman, MD; Long, MD; Martin, CF; Sandler, RS, 2016)
"Five patients had recurrences and were treated as outpatients without antibiotics."1.42Outpatient, non-antibiotic management in acute uncomplicated diverticulitis: a prospective study. ( Andreasson, K; Chabok, A; Isacson, D; Nikberg, M; Smedh, K; Thorisson, A, 2015)
"Nonalcoholic fatty liver disease (NAFLD) represents a spectrum of liver damage ranging from steatosis to nonalcoholic steatohepatitis (NASH) and cirrhosis."1.39Altered UDP-glucuronosyltransferase and sulfotransferase expression and function during progressive stages of human nonalcoholic fatty liver disease. ( Cherrington, NJ; Ferreira, DW; Hardwick, RN; Lake, AD; Lu, Z; Manautou, JE; More, VR; Slitt, AL, 2013)
"Irreversible acute liver failure, defined as rise in prothrombin time >3 times normal, occurred 19."1.39A reproducible, clinically relevant, intensively managed, pig model of acute liver failure for testing of therapies aimed to prolong survival. ( Alibhai, H; Baker, LA; Chang, YM; Davies, NA; Jalan, R; L Priestnall, S; Leckie, PJ; Lee, KC; Mookerjee, RP; Palacios Jimenez, C; Stanzani, G, 2013)
"Acetaminophen is a safe antipyretic and analgesic drug within the clinically recommended dosage range, but overdose can cause fatal liver and or kidney damage."1.38Effect of acetaminophen on the progression of renal damage in adenine induced renal failure model rats. ( Arimizu, K; Chuang, VT; Hirata, S; Irie, T; Ishitsuka, Y; Kadowaki, D; Kitamura, K; Maruyama, T; Narita, Y; Otagiri, M; Sumikawa, S; Taguchi, K, 2012)
"Progression of hepatic encephalopathy (HE) is a major determinant of outcome in acute liver failure (ALF)."1.32Infection and the progression of hepatic encephalopathy in acute liver failure. ( Blei, AT; Chung, C; Helenowski, I; Lee, WM; Polson, J; Reisch, J; Schiodt, FV; Vaquero, J, 2003)
"C57BL/6 mice were administered a toxic dose of APAP intraperitoneally to cause liver injury with or without depletion of NK and NKT cells by anti-NK1."1.32Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. ( Govindarajan, S; Kaplowitz, N; Liu, ZX, 2004)
"No effect of disease state, AIDS vs asymptomatic HIV positive vs control, on APAP glucuronidation or sulphation was observed."1.30Glucuronidation and sulphation of paracetamol in HIV-positive patients and patients with AIDS. ( Di Girolamo, A; O'Neil, WM; Pezzullo, JC; Tsoukas, CM; Wainer, IW, 1999)

Research

Studies (58)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (1.72)18.2507
2000's17 (29.31)29.6817
2010's33 (56.90)24.3611
2020's7 (12.07)2.80

Authors

AuthorsStudies
von Meijenfeldt, FA1
Stravitz, RT1
Zhang, J1
Adelmeijer, J1
Zen, Y1
Durkalski, V1
Lee, WM2
Lisman, T1
de Bruin, N1
Schneider, AK1
Reus, P1
Talmon, S1
Ciesek, S1
Bojkova, D1
Cinatl, J1
Lodhi, I1
Charlesworth, B1
Sinclair, S1
Pennick, G1
Laughey, WF1
Gribbon, P1
Kannt, A1
Schiffmann, S1
Kelly, TL1
Ward, M1
Pratt, NL1
Ramsay, E1
Gillam, M1
Roughead, EE1
Karpińska, G1
Dobrowolski, JC1
Yinda, CK1
Rector, A1
Zeller, M1
Conceição-Neto, N1
Heylen, E1
Maes, P1
Ghogomu, SM1
Van Ranst, M1
Matthijnssens, J1
Arthanari, SK1
Vanitha, J1
Ganesh, M1
Venkateshwaran, K1
de Lama Caro-Patón, G1
García-Salido, A1
Iglesias-Bouzas, MI1
Guillén, M1
Cañedo-Villaroya, E1
Martínez-Romera, I1
Serrano-González, A1
Casado-Flores, J1
Gale, P2
Chen, X2
Li, H1
Lucero-Prisno, DE1
Abdullah, AS1
Huang, J1
Laurence, C1
Liang, X1
Ma, Z1
Mao, Z1
Ren, R1
Wu, S1
Wang, N1
Wang, P2
Wang, T1
Yan, H1
Zou, Y1
Olsen, KM1
Gabler, NK1
Rademacher, CJ1
Schwartz, KJ1
Schweer, WP1
Gourley, GG1
Patience, JF1
Rauch, JC1
Stokes, RS1
Shike, DW1
Luebbe, KM1
Stalker, LA1
Klopfenstein, TJ1
Funston, RN1
Unger, PA1
Lighaam, LC1
Vermeulen, E1
Kruithof, S1
Makuch, M1
Culver, EL1
van Bruggen, R1
Remmerswaal, EBM1
Ten Berge, IJM1
Emmens, RW1
Niessen, HWM1
Barnes, E1
Wolbink, GJ1
van Ham, SM1
Rispens, T1
Liang, JX1
Lin, J1
Liu, J1
Wang, X1
Zhang, T1
Li, J1
Wu, Y2
Venier, M1
Salamova, A1
Gonçales, VR1
Lian, J1
Gautam, S1
Tilley, RD1
Gooding, JJ1
Kandel, YR1
Bradley, CA1
Chilvers, MI1
Mathew, FM1
Tenuta, AU1
Smith, DL1
Wise, KA1
Mueller, DS1
Lu, N1
Lu, M1
Liu, P1
Xu, H1
Qiu, X1
Hu, S1
Bai, S1
Wu, J1
Xue, S1
Dai, X1
Dharmage, SC1
Abramson, MJ1
Erbas, B1
Bennett, CM1
Svanes, C1
Hui, J1
Axelrad, C1
Lowe, AJ1
Lodge, CJ1
Hoshi, M1
Osawa, Y1
Nakamoto, K1
Morita, N1
Yamamoto, Y1
Ando, T1
Tashita, C1
Nabeshima, T1
Saito, K1
Gianesello, L1
Del Prete, D1
Ceol, M1
Priante, G1
Calò, LA1
Anglani, F1
Vekaria, HJ1
Hubbard, WB1
Scholpa, NE1
Spry, ML1
Gooch, JL1
Prince, SJ1
Schnellmann, RG1
Sullivan, PG1
Zhang, Q1
Hu, R1
Gu, Z1
Zhang, M1
Zhang, Z1
Peng, Y1
Feng, L1
Li, X3
Zhao, C1
Sarfaraz, K1
Gao, L1
Wang, H1
Wan, C1
Leng, J1
Yang, P1
Gao, X1
Gao, J1
Emam, HE1
Saad, NM1
Abdallah, AEM1
Ahmed, HB1
Palombo, M1
Ianus, A1
Guerreri, M1
Nunes, D1
Alexander, DC1
Shemesh, N1
Zhang, H1
Xiong, Q1
Liu, YS1
Hu, LX1
Shi, ZQ1
Ying, GG1
Chen, R1
Hong, X1
Yan, S1
Zha, J1
Gu, H1
Zhong, Q1
Zeng, Y1
Zhang, S1
Bu, Y1
Farghali, M1
Mayumi, M1
Syo, K1
Satoshi, A1
Seiichi, Y1
Takashima, S1
Ono, H1
Ap, Y1
Yamashiro, T1
Ahmed, MM1
Kotb, S1
Iwasaki, M1
Ihara, I1
Umetsu, K1
Hu, B2
Wang, Y2
Quan, J1
Huang, K1
Gu, X1
Zhu, J1
Yan, Y1
Wu, P1
Yang, L1
Zhao, J1
Koók, L1
Nemestóthy, N1
Bélafi-Bakó, K1
Bakonyi, P1
Luo, X1
Zhang, F1
Li, Q1
Xia, Q1
Li, Z1
Ye, W1
Li, S1
Ge, C1
Zakkula, A1
Pulipati, S1
Dittakavi, S1
Bestha, RM1
Zainuddin, M1
Trivedi, RK1
Mullangi, R1
Lo, GH1
Lin, CW1
Tai, CM1
Perng, DS1
Chen, IL1
Yeh, JH1
Lin, HC1
Rocha, GS1
Silva, MKL1
Cesarino, I1
Hazzaa, SM1
Abdelaziz, SAM1
Abd Eldaim, MA1
Abdel-Daim, MM1
Elgarawany, GE1
Larsson, P1
Ljuslinder, I1
Öhlund, D1
Myte, R1
Löfgren-Burström, A1
Zingmark, C1
Ling, A1
Edin, S1
Palmqvist, R1
Murthi, P1
Rajaraman, G1
Erwich, JJHM1
Dimitriadis, E1
Yoon, HG1
Oh, D1
Ahn, YC1
Noh, JM1
Pyo, H1
Cho, WK1
Song, YM1
Park, M1
Hwang, NY1
Sun, JM1
Kim, HK1
Zo, JI1
Shim, YM1
Persano, A1
Quaranta, F1
Taurino, A1
Siciliano, PA1
Iannacci, J1
Malekbala, MR1
Soltani, S1
Abdul Rashid, S1
Abdullah, LC1
Rashid, U1
Nehdi, IA1
Choong, TSY1
Teo, SH1
Xu, P1
Yan, F1
Zhao, Y1
Sun, S1
Ying, L1
Quinzi, V1
Caruso, S1
Mummolo, S1
Nota, A1
Angelone, AM1
Mattei, A1
Gatto, R1
Marzo, G1
Xin, W1
Severino, J1
Venkert, A1
Yu, H1
Knorr, D1
Yang, JM1
Carlson, L1
Hicks, R1
De Rosa, I1
Beckmann, NA1
Bitsch, RG1
Schonhoff, M1
Siebenrock, KA1
Schwarze, M1
Jaeger, S1
Sherbash, M1
Furuya-Kanamori, L1
Nader, JD1
Thalib, L1
Mitsuboshi, S1
Yamada, H1
Yamazaki, S1
Kobayashi, M1
Ueno, K1
Nagai, K1
Reamy, BV1
Servey, JT1
Williams, PM1
van Dam, PH1
Achterberg, WP1
Husebo, BS1
Caljouw, MAA1
Lee, KCL1
Baker, L1
Mallett, S1
Riddell, A1
Chowdary, P1
Alibhai, H2
Chang, YM2
Priestnall, S1
Stanzani, G2
Davies, N1
Mookerjee, R1
Jalan, R3
Agarwal, B1
Calvo, PL1
Tandoi, F1
Haak, TB1
Brunati, A1
Pinon, M1
Olio, DD1
Romagnoli, R1
Spada, M1
Zabron, A1
Quaglia, A1
Fatourou, E1
Peddu, P1
Lewis, D1
Heneghan, M1
Willars, C1
Auzinger, G1
Heaton, N1
Wendon, J1
Kane, P1
Karani, J1
Bernal, W1
Moninuola, OO1
Milligan, W1
Lochhead, P1
Khalili, H1
Heinzl, S1
Mitsui, S1
Katayama, C1
Aoyama, Y1
Mizukawa, Y1
Kuyama, M1
Kawakami, Y1
Vickers, AEM1
Ulyanov, AV1
Fisher, RL1
Nicholas, WA1
Moore, R1
Fisher, ES1
Curry, SC1
Shah, N1
Montes de Oca, M1
Jover-Cobos, M1
Tanamoto, K1
Muroi, M1
Sugiyama, K1
Davies, NA2
Mookerjee, RP2
Dhar, DK1
Cavassani, KA1
Moreira, AP1
Habiel, D1
Ito, T1
Coelho, AL1
Allen, RM1
Raphelson, J1
Carson, WF1
Schaller, MA1
Lukacs, NW1
Omary, MB2
Hogaboam, CM1
Kunkel, SL1
El Sayed, SM1
Mohamed, WG1
Seddik, MA1
Ahmed, AS1
Mahmoud, AG1
Amer, WH1
Helmy Nabo, MM1
Hamed, AR1
Ahmed, NS1
Abd-Allah, AA1
Guldiken, N1
Zhou, Q1
Kucukoglu, O1
Rehm, M1
Levada, K1
Gross, A1
Kwan, R1
James, LP1
Trautwein, C1
Strnad, P1
Isacson, D1
Thorisson, A1
Andreasson, K1
Nikberg, M1
Smedh, K1
Chabok, A1
Szabo, G1
Petrasek, J1
Long, MD1
Kappelman, MD1
Martin, CF1
Chen, W1
Anton, K1
Sandler, RS1
Kucharz, EJ1
Kovalenko, V1
Szántó, S1
Bruyère, O1
Cooper, C1
Reginster, JY1
Venkatesan, P1
Srivastava, R1
Das, SK1
Goel, G1
Asthana, A1
Agarwal, GG1
Sakulchit, T1
Goldman, RD1
Wei, G1
Kalaitzakis, E1
Bergquist, A1
Björnsson, E1
Tan, HH1
Chang, CY1
Martin, P1
Mehta, G1
Rothstein, KD1
Lopez, DP1
Malfait, AM1
Ritchie, J1
Gil, AS1
Austin, JS1
Hartke, J1
Qin, W1
Tortorella, MD1
Mogil, JS1
Newsome, PN1
Henderson, NC1
Nelson, LJ1
Dabos, C1
Filippi, C1
Bellamy, C1
Howie, F1
Clutton, RE1
King, T1
Lee, A1
Hayes, PC1
Plevris, JN1
Kuo, HW1
Tsai, SS1
Tiao, MM1
Liu, YC1
Lee, IM1
Yang, CY1
Bhave, VS2
Donthamsetty, S1
Latendresse, JR2
Cunningham, ML1
Mehendale, HM4
Dzielska-Olczak, M1
Nowak, JZ1
Pagano, MB1
Hobbs, W1
Linenberger, M1
Delaney, M1
Carbone, LD1
Satterfield, S1
Liu, C1
Kwoh, KC1
Neogi, T1
Tolley, E1
Nevitt, M1
Kadowaki, D1
Sumikawa, S1
Arimizu, K1
Taguchi, K1
Kitamura, K1
Ishitsuka, Y1
Narita, Y1
Irie, T1
Chuang, VT1
Maruyama, T1
Otagiri, M1
Hirata, S1
Uehara, T1
Kosyk, O1
Jeannot, E1
Bradford, BU1
Tech, K1
Macdonald, JM1
Boorman, GA1
Chatterjee, S1
Mason, RP1
Melnyk, SB1
Tryndyak, VP1
Pogribny, IP1
Rusyn, I1
Hardwick, RN1
Ferreira, DW1
More, VR1
Lake, AD1
Lu, Z1
Manautou, JE1
Slitt, AL1
Cherrington, NJ1
Lee, KC1
Palacios Jimenez, C1
Leckie, PJ1
Baker, LA1
L Priestnall, S1
Takagi, K1
Vaquero, J1
Polson, J1
Chung, C1
Helenowski, I1
Schiodt, FV1
Reisch, J1
Blei, AT1
Limaye, PB2
Apte, UM2
Shankar, K1
Bucci, TJ1
Warbritton, A1
Bove, SE1
Calcaterra, SL1
Brooker, RM1
Huber, CM1
Guzman, RE1
Juneau, PL1
Schrier, DJ1
Kilgore, KS1
Liu, ZX1
Govindarajan, S1
Kaplowitz, N1
Wu, CW1
Kalunian, KC1
Rosmawati, M1
Mahajan, A1
Verma, S1
Tandon, V1
Palkar, PS1
Sawant, SP1
Yu, S1
Reddy, JK1
Schmidt, LE1
Larsen, FS1
O'Neil, WM1
Pezzullo, JC1
Di Girolamo, A1
Tsoukas, CM1
Wainer, IW1
Friedman, RA1
House, JW1
Luxford, WM1
Gherini, S1
Mills, D1
Boysen, G1
Christensen, H1
Bourdi, M1
Reilly, TP1
Elkahloun, AG1
George, JW1
Pohl, LR1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Randomized Multicentric Controlled Clinical Trial of Parallel Groups to Evaluate the Non-therapeutic Inferiority of a Free Diet With a Progressive Diet, in the Treatment of Non-complicated Acute Diverticulitis[NCT03496090]134 participants (Actual)Interventional2018-04-16Completed
A Multi-Center Trial to Study Acute Liver Failure in Adults[NCT00518440]3,488 participants (Actual)Observational1998-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

15 reviews available for acetaminophen and Disease Exacerbation

ArticleYear
    Computational & theoretical chemistry, 2013, Feb-01, Volume: 1005

    Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Am

2013
Risk of wheezing and asthma exacerbation in children treated with paracetamol versus ibuprofen: a systematic review and meta-analysis of randomised controlled trials.
    BMC pulmonary medicine, 2020, Mar-23, Volume: 20, Issue:1

    Topics: Acetaminophen; Asthma; Child; Disease Progression; Humans; Ibuprofen; Randomized Controlled Trials a

2020
Henoch-Schönlein Purpura (IgA Vasculitis): Rapid Evidence Review.
    American family physician, 2020, 08-15, Volume: 102, Issue:4

    Topics: Acetaminophen; Adrenal Cortex Hormones; Adult; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, N

2020
Systematic review with meta-analysis: association between acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) and risk of Crohn's disease and ulcerative colitis exacerbation.
    Alimentary pharmacology & therapeutics, 2018, Volume: 47, Issue:11

    Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Colitis, Ulcerative; C

2018
Evaluation and treatment of acetaminophen toxicity.
    Advances in pharmacology (San Diego, Calif.), 2019, Volume: 85

    Topics: Acetaminophen; Acute Disease; Animals; Chemical and Drug Induced Liver Injury; Disease Progression;

2019
Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study.
    Chinese journal of cancer, 2014, Volume: 33, Issue:7

    Topics: Acetaminophen; Adult; Carcinoma, Hepatocellular; Disease Progression; Drug Therapy, Combination; Enz

2014
Inflammasome activation and function in liver disease.
    Nature reviews. Gastroenterology & hepatology, 2015, Volume: 12, Issue:7

    Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Disease Prog

2015
A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes.
    Current medical research and opinion, 2016, Volume: 32, Issue:6

    Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Dietary Supplements; Disease Progression; Gl

2016
Acetaminophen use and asthma in children.
    Canadian family physician Medecin de famille canadien, 2017, Volume: 63, Issue:3

    Topics: Acetaminophen; Age Factors; Antipyretics; Asthma; Child; Child, Preschool; Disease Progression; Dose

2017
Health maintenance issues in cirrhosis.
    The Medical clinics of North America, 2009, Volume: 93, Issue:4

    Topics: Acetaminophen; Alcohol Drinking; Analgesics, Non-Narcotic; Comorbidity; Disease Progression; Health

2009
Emergency: acetaminophen poisoning.
    The American journal of nursing, 2009, Volume: 109, Issue:9

    Topics: Acetaminophen; Acetylcysteine; Adolescent; Antidotes; Charcoal; Chemical and Drug Induced Liver Inju

2009
Once initiated, how does toxic tissue injury expand?
    Trends in pharmacological sciences, 2012, Volume: 33, Issue:4

    Topics: Acetaminophen; Animals; Calpain; Cell Death; Disease Progression; Free Radicals; Humans; Soft Tissue

2012
[Antiinflammatory therapy in ostheoarthritis including omega 3 and omega 6 fatty acids].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2012, Volume: 32, Issue:191

    Topics: Acetaminophen; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Chondroitin Sulfat

2012
New developments in osteoarthritis.
    Clinics in geriatric medicine, 2005, Volume: 21, Issue:3

    Topics: Acetaminophen; Acupuncture Therapy; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non

2005
Osteoarthritis.
    The Journal of the Association of Physicians of India, 2005, Volume: 53

    Topics: Acetaminophen; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Bone Remodeling; Cartilage, Art

2005

Trials

4 trials available for acetaminophen and Disease Exacerbation

ArticleYear
    Computational & theoretical chemistry, 2013, Feb-01, Volume: 1005

    Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Am

2013
Does paracetamol improve quality of life, discomfort, pain and neuropsychiatric symptoms in persons with advanced dementia living in long-term care facilities? A randomised double-blind placebo-controlled crossover (Q-PID) trial.
    BMC medicine, 2020, 12-21, Volume: 18, Issue:1

    Topics: Acetaminophen; Aged; Aged, 80 and over; Cross-Over Studies; Dementia; Disease Progression; Double-Bl

2020
[In process].
    Medizinische Monatsschrift fur Pharmazeuten, 2016, Volume: 39, Issue:10

    Topics: Acetaminophen; Asthma; Child, Preschool; Disease Progression; Fever; Humans; Ibuprofen; Pain; Prospe

2016
Stroke severity determines body temperature in acute stroke.
    Stroke, 2001, Volume: 32, Issue:2

    Topics: Acetaminophen; Acute Disease; Aged; Aged, 80 and over; Anticoagulants; Body Temperature; Cerebral He

2001

Other Studies

40 other studies available for acetaminophen and Disease Exacerbation

ArticleYear
Generation of neutrophil extracellular traps in patients with acute liver failure is associated with poor outcome.
    Hepatology (Baltimore, Md.), 2022, Volume: 75, Issue:3

    Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Cell-Free Nucleic Acids; Disease Progression; Extrac

2022
Ibuprofen, Flurbiprofen, Etoricoxib or Paracetamol Do Not Influence ACE2 Expression and Activity In Vitro or in Mice and Do Not Exacerbate In-Vitro SARS-CoV-2 Infection.
    International journal of molecular sciences, 2022, Jan-19, Volume: 23, Issue:3

    Topics: Acetaminophen; Angiotensin-Converting Enzyme 2; Animals; Anti-Inflammatory Agents, Non-Steroidal; Ca

2022
The association between exacerbation of chronic obstructive pulmonary disease and timing of paracetamol use: a cohort study in elderly Australians.
    Respiratory research, 2022, Apr-05, Volume: 23, Issue:1

    Topics: Acetaminophen; Aged; Australia; Cohort Studies; Disease Progression; Humans; Pulmonary Disease, Chro

2022
[Is Concomitant Therapy with Acetaminophen and Low-dose Aspirin a Risk Factor for CKD Progression? A 6-Year Cohort Study].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2020, Volume: 140, Issue:7

    Topics: Acetaminophen; Adult; Age Factors; Aged; Aged, 80 and over; Aspirin; Biomarkers; Creatinine; Diabete

2020
Hypercoagulability progresses to hypocoagulability during evolution of acetaminophen-induced acute liver injury in pigs.
    Scientific reports, 2017, 08-24, Volume: 7, Issue:1

    Topics: Acetaminophen; Animals; Biomarkers; Blood Cell Count; Blood Coagulation; Blood Coagulation Factors;

2017
NBAS mutations cause acute liver failure: when acetaminophen is not a culprit.
    Italian journal of pediatrics, 2017, Sep-25, Volume: 43, Issue:1

    Topics: Acetaminophen; Diagnosis, Differential; Disease Progression; Fever; Genetic Predisposition to Diseas

2017
Clinical and prognostic associations of liver volume determined by computed tomography in acute liver failure.
    Liver international : official journal of the International Association for the Study of the Liver, 2018, Volume: 38, Issue:9

    Topics: Acetaminophen; Adult; Budd-Chiari Syndrome; Decision Support Techniques; Disease Progression; Female

2018
Local desensitization and progression of multiple fixed drug eruption.
    European journal of dermatology : EJD, 2018, Jun-01, Volume: 28, Issue:3

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Disease Progression; Drug Eruptions; Erythema; Female; Huma

2018
Progression of Repair and Injury in Human Liver Slices.
    International journal of molecular sciences, 2018, Dec-19, Volume: 19, Issue:12

    Topics: Acetaminophen; Adenosine Triphosphate; Diclofenac; Disease Progression; Gene Expression Regulation;

2018
Using the 150 rule to prevent hepatotoxicity from acetaminophen.
    JAAPA : official journal of the American Academy of Physician Assistants, 2019, Volume: 32, Issue:4

    Topics: Acetaminophen; Acetylcysteine; Adolescent; Diagnosis, Differential; Disease Progression; Drug Overdo

2019
Role of toll-like receptor 4 in mediating multiorgan dysfunction in mice with acetaminophen induced acute liver failure.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2013, Volume: 19, Issue:7

    Topics: Acetaminophen; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Brain; Cytokines; D

2013
Toll like receptor 3 plays a critical role in the progression and severity of acetaminophen-induced hepatotoxicity.
    PloS one, 2013, Volume: 8, Issue:6

    Topics: Acetaminophen; Animals; Antibodies, Neutralizing; Chemical and Drug Induced Liver Injury; Chemokines

2013
Human keratin 8 variants promote mouse acetaminophen hepatotoxicity coupled with c-jun amino-terminal kinase activation and protein adduct formation.
    Hepatology (Baltimore, Md.), 2015, Volume: 62, Issue:3

    Topics: Acetaminophen; Animals; Disease Models, Animal; Disease Progression; Gene Expression Regulation; Hum

2015
Outpatient, non-antibiotic management in acute uncomplicated diverticulitis: a prospective study.
    International journal of colorectal disease, 2015, Volume: 30, Issue:9

    Topics: Abdominal Abscess; Abdominal Pain; Acetaminophen; Acute Disease; Aged; Ambulatory Care; Analgesics;

2015
Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel Disease.
    Journal of clinical gastroenterology, 2016, Volume: 50, Issue:2

    Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ul

2016
Paracetamol no worse than ibuprofen in children with mild asthma.
    The Lancet. Respiratory medicine, 2016, Volume: 4, Issue:10

    Topics: Acetaminophen; Asthma; Child; Child, Preschool; Disease Progression; Female; Humans; Ibuprofen; Male

2016
Does long term colchicine prevent degradation of collagen fiber network in osteoarthritis?
    International journal of rheumatic diseases, 2018, Volume: 21, Issue:1

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Antirheumatic Agents; Biomarkers; Cartilage Oligomeric Matr

2018
Long-term follow-up of patients with acute liver failure of indeterminate aetiology.
    Scandinavian journal of gastroenterology, 2008, Volume: 43, Issue:8

    Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Budd-Chiari Syndrome; Disease Progression; Female; F

2008
Acetaminophen hepatotoxicity: current management.
    The Mount Sinai journal of medicine, New York, 2009, Volume: 76, Issue:1

    Topics: Acetaminophen; Acetylcysteine; Antidotes; Charcoal; Chemical and Drug Induced Liver Injury; Cimetidi

2009
ADAMTS-5 deficient mice do not develop mechanical allodynia associated with osteoarthritis following medial meniscal destabilization.
    Osteoarthritis and cartilage, 2010, Volume: 18, Issue:4

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Behavior, Animal; Disease Mode

2010
Development of an invasively monitored porcine model of acetaminophen-induced acute liver failure.
    BMC gastroenterology, 2010, Mar-30, Volume: 10

    Topics: Acetaminophen; Animals; Cytochrome P-450 Enzyme System; Disease Models, Animal; Disease Progression;

2010
Analgesic use and the risk for progression of chronic kidney disease.
    Pharmacoepidemiology and drug safety, 2010, Volume: 19, Issue:7

    Topics: Acetaminophen; Adolescent; Adult; Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Aspirin

2010
Secretory phospholipase A₂-mediated progression of hepatotoxicity initiated by acetaminophen is exacerbated in the absence of hepatic COX-2.
    Toxicology and applied pharmacology, 2011, Mar-15, Volume: 251, Issue:3

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Chemical and Drug Induced Liver Injury; Cyclooxyge

2011
Plasma and red cell exchange transfusions for erythropoietic protoporphyria: a case report and review of the literature.
    Journal of clinical apheresis, 2012, Volume: 27, Issue:6

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Arthroplasty, Replacement, Knee; Cholestasis, Intrahepatic;

2012
Assistive walking device use and knee osteoarthritis: results from the Health, Aging and Body Composition Study (Health ABC Study).
    Archives of physical medicine and rehabilitation, 2013, Volume: 94, Issue:2

    Topics: Acetaminophen; Age Factors; Aged; Analgesics, Non-Narcotic; Canes; Disease Progression; Eye Diseases

2013
Effect of acetaminophen on the progression of renal damage in adenine induced renal failure model rats.
    Life sciences, 2012, Dec-17, Volume: 91, Issue:25-26

    Topics: Acetaminophen; Adenine; Administration, Oral; Analgesics, Non-Narcotic; Animals; Antioxidants; Disea

2012
Acetaminophen-induced acute liver injury in HCV transgenic mice.
    Toxicology and applied pharmacology, 2013, Jan-15, Volume: 266, Issue:2

    Topics: Acetaminophen; Acute Disease; Analgesics, Non-Narcotic; Animals; Chemical and Drug Induced Liver Inj

2013
Altered UDP-glucuronosyltransferase and sulfotransferase expression and function during progressive stages of human nonalcoholic fatty liver disease.
    Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:3

    Topics: Acetaminophen; Biotransformation; Disease Progression; Fatty Liver; Gene Expression Regulation, Enzy

2013
A reproducible, clinically relevant, intensively managed, pig model of acute liver failure for testing of therapies aimed to prolong survival.
    Liver international : official journal of the International Association for the Study of the Liver, 2013, Volume: 33, Issue:4

    Topics: Acetaminophen; Acid-Base Equilibrium; Acidosis; Animals; Biomarkers; Cardiovascular Diseases; Chemic

2013
Body temperature in acute stroke.
    Stroke, 2002, Volume: 33, Issue:9

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Body Temperature; Disease Progression; Fever; Huma

2002
Infection and the progression of hepatic encephalopathy in acute liver failure.
    Gastroenterology, 2003, Volume: 125, Issue:3

    Topics: Acetaminophen; Adult; Disease Progression; Female; Hepatic Encephalopathy; Humans; Infections; Liver

2003
Calpain released from dying hepatocytes mediates progression of acute liver injury induced by model hepatotoxicants.
    Toxicology and applied pharmacology, 2003, Sep-15, Volume: 191, Issue:3

    Topics: Acetaminophen; Animals; Blotting, Western; Calpain; Carbon Tetrachloride; Carrier Proteins; Chemical

2003
Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis.
    Osteoarthritis and cartilage, 2003, Volume: 11, Issue:11

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis

2003
Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity.
    Gastroenterology, 2004, Volume: 127, Issue:6

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Cytokines; Disease Progression; Female; Humans; Ki

2004
Aetiology and classification of acute liver failure.
    The Medical journal of Malaysia, 2005, Volume: 60 Suppl B

    Topics: Acetaminophen; Disease Progression; Hepatitis A; Hepatitis B; Humans; Liver Failure, Acute; Risk Fac

2005
Upregulation of calpastatin in regenerating and developing rat liver: role in resistance against hepatotoxicity.
    Hepatology (Baltimore, Md.), 2006, Volume: 44, Issue:2

    Topics: Acetaminophen; Animals; Animals, Newborn; Calcium-Binding Proteins; Calpain; Carbon Tetrachloride; C

2006
MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury.
    Hepatology (Baltimore, Md.), 2007, Volume: 45, Issue:3

    Topics: Acetaminophen; Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Child; Disease

2007
Glucuronidation and sulphation of paracetamol in HIV-positive patients and patients with AIDS.
    British journal of clinical pharmacology, 1999, Volume: 48, Issue:6

    Topics: Acetaminophen; Acquired Immunodeficiency Syndrome; Adult; Cross-Sectional Studies; Disease Progressi

1999
Profound hearing loss associated with hydrocodone/acetaminophen abuse.
    The American journal of otology, 2000, Volume: 21, Issue:2

    Topics: Acetaminophen; Adult; Analgesics; Cochlear Implantation; Disease Progression; Drug Combinations; Fem

2000
Macrophage migration inhibitory factor in drug-induced liver injury: a role in susceptibility and stress responsiveness.
    Biochemical and biophysical research communications, 2002, Jun-07, Volume: 294, Issue:2

    Topics: Acetaminophen; Alanine Transaminase; Animals; Biomarkers; Biotransformation; Chemical and Drug Induc

2002